Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.
Aversa
Savina Maria Luciana
SM
Trentin
Chiara
C
Sorarů
Mariella
M
Di Bona
Eros
E
Marino
Dario
D
Canova
Fabio
F
Salvagno
Luigi
L
Adami
Fausto
F
D000328:Adult; D000970:Antineoplastic Agents / Q000494:pharmacology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000378:metabolism; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy*; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000209:etiology*; D008466:Mechlorethamine / Q000627:therapeutic use; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D016896:Treatment Outcome; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D001761:Bleomycin; D016179:Granulocyte Colony-Stimulating Factor; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D005047:Etoposide; D004317:Doxorubicin; D011241:Prednisone